Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

WHAM continues its coverage of National Diabetes Month with a look at some tools to manage it and foods to consider adding to ...

The National Accreditation Board for Hospitals and Healthcare Providers (NABH), a constituent body of  Quality Council of India (QCI), on Tuesday inked a pact with the Research Society for the Study ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

There could be a simple way to lower your blood sugar levels and reduce your risk of heart disease - and it involves adding a ...

Diabetes does not discriminate with age.Though adults aged 45–64 receive the majority of new diabetes diagnoses in the U.S., ...

Diabetic hypoglycemia occurs when a person's blood sugar level falls too low. Symptoms can include: shakiness, confusion or ...

The collaboration between NABH and RSSDI seeks to elevate diabetes care quality by establishing robust accreditation ...

Discover the truth behind Sugar Defender with real customer insights and detailed Sugar Defender reviews – is it for you?

Emcure Pharma’s SAKHI - Diabetes Awareness Programme makes it to Asia Book of Records: Our Bureau, Mumbai Tuesday, November 19, 2024, 15:30 Hrs [IST] Emcure Pharmaceuticals, a l ...

Dr. Michael Jurua, the head of the private wing at Arua Regional Referral Hospital, emphasized that regular screening makes ...

Manoj Chowdary Vattikuti, Sr. DevOps Engineer and Research Scientist at Cardinal Health, along with Niharikareddy Meenigea, ...